Adventures in Finance: A Real Vision Podcast   /     The Major Corporate Solvency Crisis: DB - Dec14, 2020

Description

Real Vision managing editor Ed Harrison is joined by editor Jack Farley to break down the growing corporate debt crisis. Ed and Jack discuss the latest report from the Group of Thirty, which finds that balance sheet impairment will complicate economic recovery and persist long after this pandemic ends. Ed crystallizes the risks into three separate categories—pandemic-related, economic, and financial—and incorporates these risks into Raoul’s framework on the “insolvency phase." Ed and Jack also discuss fiscal aid, sector rotation, and lockdowns in the U.S. and Europe. In the intro, Real Vision's Peter Cooper discusses the joyous news of the beginnings of vaccine distribution in the U.S., AstraZeneca's announcement to acquire Alexion Pharmaceuticals, and the sterling's rally on renewed Brexit trade negotiations. Learn more about your ad choices. Visit megaphone.fm/adchoices

Subtitle
Real Vision managing editor Ed Harrison is joined by editor Jack Farley to break down the growing corporate debt crisis.
Duration
2577
Publishing date
2020-12-14 23:14
Link
https://example.com
Contributors
  Real Vision
author  
Enclosures
https://chtbl.com/track/1B146C/traffic.megaphone.fm/ADV6954649063.mp3
audio/mpeg

Shownotes

Real Vision managing editor Ed Harrison is joined by editor Jack Farley to break down the growing corporate debt crisis. Ed and Jack discuss the latest report from the Group of Thirty, which finds that balance sheet impairment will complicate economic recovery and persist long after this pandemic ends. Ed crystallizes the risks into three separate categories—pandemic-related, economic, and financial—and incorporates these risks into Raoul’s framework on the “insolvency phase." Ed and Jack also discuss fiscal aid, sector rotation, and lockdowns in the U.S. and Europe. In the intro, Real Vision's Peter Cooper discusses the joyous news of the beginnings of vaccine distribution in the U.S., AstraZeneca's announcement to acquire Alexion Pharmaceuticals, and the sterling's rally on renewed Brexit trade negotiations.

Learn more about your ad choices. Visit megaphone.fm/adchoices